MML Investors Services’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,313
Closed -$560K 3178
2025
Q4
$560K Buy
13,313
+2,077
+18% +$83.7K ﹤0.01% 2184
2025
Q3
$386K Buy
11,236
+521
+5% +$14.9K ﹤0.01% 2342
2025
Q2
$290K Buy
10,715
+1,130
+12% +$32.7K ﹤0.01% 2459
2025
Q1
$284K Buy
9,585
+1,629
+20% +$62.1K ﹤0.01% 2341
2024
Q4
$315K Sell
7,956
-1,536
-16% -$58.2K ﹤0.01% 2229
2024
Q3
$323K Sell
9,492
-74
-0.8% -$2.08K ﹤0.01% 2126
2024
Q2
$207K Sell
9,566
-737
-7% -$15.5K ﹤0.01% 2326
2024
Q1
$228K Sell
10,303
-399
-4% -$9.73K ﹤0.01% 2288
2023
Q4
$294K Buy
10,702
+1,725
+19% +$41.6K ﹤0.01% 2056
2023
Q3
$200K Buy
8,977
+430
+5% +$11.1K ﹤0.01% 2158
2023
Q2
$218K Buy
+8,547
New +$207K ﹤0.01% 2130

Other funds holding VCYT

MML Investors Services's VCYT Position: Q1 2026 in Review

MML Investors Services sold out of Veracyte (VCYT) in Q1 2026, closing a stake of 13,313 shares — an estimated $560K sold.

MML Investors Services first reported a position in VCYT in Q2 2023 and held it in 11 quarters. The position peaked at $560K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • MML Investors Services reported no remaining Veracyte position as of Q1 2026 after selling out during the quarter.
  • MML Investors Services sold 13,313 Veracyte shares in Q1 2026, an estimated $560K.
  • MML Investors Services first reported a position in Veracyte in Q2 2023 and held it in 11 quarters.
  • MML Investors Services's Veracyte position peaked at $560K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on MML Investors Services's 13F filing for Q1 2026, filed 4 May 2026.